Status:
COMPLETED
The LEARN Study for CVD Prevention
Lead Sponsor:
Yale University
Collaborating Sponsors:
National Heart, Lung, and Blood Institute (NHLBI)
Conditions:
Cardiovascular Diseases
Eligibility:
MALE
30-65 years
Phase:
NA
Brief Summary
The investigator is testing a virtual environment to address prevention of HIV-related comorbidities.
Detailed Description
The primary aims of this study are to test the feasibility, acceptability and preliminary effects of a VE to address prevention of HIV-related comorbidities. A waitlist control feasibility clinical tr...
Eligibility Criteria
Inclusion
- identify as an ethnic/racial minority with HIV
- identify as gay, same-gender-loving, or MSM
- able to read and understand English
- access to a computer capable of downloading and running the VE software
- no medical history of serious cardiovascular or cognitive complications
Exclusion
- Anything outside of inclusion parameters, including history of:
- myocardial infarction (MI)
- congestive heart failure (CHF)
- coronary artery bypass graft (CABG)
- cerebral vascular accident (CVA)
- cognitive impairment
Key Trial Info
Start Date :
May 10 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 31 2025
Estimated Enrollment :
78 Patients enrolled
Trial Details
Trial ID
NCT05242952
Start Date
May 10 2023
End Date
March 31 2025
Last Update
July 28 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Yale University
Orange, Connecticut, United States, 06477